约 40,000 个结果
在新选项卡中打开链接
Pharma, Biotech and Generics Industry News | The Pharmaletter
Pharma USA 2025 - The Pharmaletter
Zealand blindsided by FDA rejection of glepaglutide
Novo Nordisk settles patent lawsuit over Ozempic
2024: Emergent trends in pharma and biotech
Novo Nordisk’s obesity newcomer monlunabant heads into Phase …
Pharmaceutical Industry News | The Pharmaletter
FDA panel flags risks as AstraZeneca seeks full Andexxa approval
Sandoz moves to resolve legacy US generic drug antitrust class …
Second FDA approval for BeiGene’s Tevimbra in 2024